Med Ed Report
While two dozen enforcement letters were sent by FDA's Office of Prescription Drug Promotion to pharma companies last year, up from 21 in 2012, none of the letters were prompted by the Bad Ad Program.
News on the University of Louisville CME program, Merck, GlobalData and BroadcastMed
With pollen season approaching its peak, drugmakers are educating doctors on a new class of allergy tablets. It could be a while before they're made available for patients.
Firms are gearing up for the detailed filing of Sunshine data later this year, after which the inquiries and disputes window will begin.
Bayer HealthCare launched an educational website for US physicians about the rare, life-threatening condition chronic thromboembolic pulmonary hypertension (CTEPH).
News on HHS, ACCME, Haymarket Medical Education and Smith & Nephew
The approach of new transparency rules, coupled with patent losses and industry's shift to specialty meds, has contributed to a big drop in the amount drugmakers are spending on promotional speaking, says ProPublica.
There is an "overwhelming need" among HCPs for greater awareness, training and education on the diagnosis and available treatment options for rare diseases, researchers suggest.
Alexion is focusing on medical education ahead of an anticipated approval of asfotase alfa for patients with hypophosphatasia, or HPP
News on the CBI Pharmaceutical Compliance Congress, Eli Lilly and New York TImes
The ACCME announced a public call for comment about its proposal to simplify the accreditation requirements and process, including revisiting a ban on commercial support logos.
It looks like, for now, journal reprints and medical textbooks are reportable items under the Sunshine Act.
News on the Federation of State Medical Boards, Haymarket Medical Education, ACCME and the Audio-Digest Foundation
A report indicates pharma companies do not agree on what research needs to be reported.
Nearly two dozen members of Congress signaled solidarity with 41 medical boards and 33 physician associations in opposing the inclusion of textbooks and reprints in Sunshine Act reporting.
News on CME Coalition, Haymarket Medical Education, American Academy of Physician Assistants and Physicians Interactive
The AHA/ACC panel that wrote the potentially practice-changing cholesterol guidelines issued last month included six members with ties to drugmakers that sell or are developing lipid medications, Pharmalot reported.
News on Bayer Healthcare, Onyx Pharmaceuticals, Lilly, J&J, CMS and Community Care Behavioral Health Organization
Janssen's hepatitis C drug Olysio (simeprevir) offers modest benefit over standard of care, but resistance in a subgroup of patients could hinder broader uptake.
A poll by consulting firm QPharma indicates doctors are in the dark about what needs to be reported and what will be revealed.
The North American Thrombosis Forum (NATF) launched an educational initiative on risk assessment and anticoagulation for stroke prevention in atrial fibrillation (AF).
Executives from the Massachusetts General Physicians Organization said their incentive program for salaried physicians boosted clinical quality.
News on Oakstone Publishing, ArcheMedx, Conventus, CircleScience and AxoGen
The agency made good on a pledge to expand Bad Ad with a web-based CME course and case studies representing common problems.
Attendance by physicians crept up in 2012, said the trade group HCEA, but overall turnout was flat, likely because exhibitors brought less personnel along to meetings.
Providers of CME are getting better at complying with accreditation criteria, several years' worth of data show, yet tougher criteria may be in store.
In addition to donning scrubs before entering the OR, several surgeons have slipped on Google Glass, the augmented-reality enabling goggles.
News on Elsevier, CDC, Southern Medical Association and Astellas
Though CME grant-giving dropped by about 10% in 2012, revenues from regsitration fees and the like surged nearly 15%
Haymarket Medical Education is taking the wraps off a totally redesigned MyCME.com portal this month
The AAFP has urged FDA to keep REMS-specific CME for extended-release and long-acting opioids voluntary
News about Pri-Med, Astellas Scientic, Medical Affairs, UCSD and CircleScience
A study by CMEology shows that CME can trim substantial costs from the healthcare system
CMS has clarified how meals and expenses are to be treated under the so-called CME exemption
ProPublica data show that a number of drug prescribers receive money from drug companies for promotional talks
News on Clinical Care Options, Global Academy for Medical Education, Association of American Medical Colleges, American Psychological Association and KnowledgePoint360
Boehringer Ingelheim and Eli Lilly rolled out a pre-launch med-ed campaign to differentiate their positioning in the SGLT2 diabetes drug class.
Navidea Biopharmaceuticals is launching Lymphoseek, its diagnostic agent used to check for cancer spread, with medical affairs, promotional education and CME aimed at the nuclear medicine community.
News on the Australian Medical Association, Sanofi, GAME, Novartis and KnowledgePoint 360
For Pfizer and GlaxoSmithKline, the effects of expiring patents on blockbuster drugs took their toll on payments to US doctors last year.
It takes nearly two years for results from the average clinical trial to be published, across all funders, according to a new study.
A whistleblower says Cephalon used CME, "bogus 'market research surveys' and Advisory Board meetings" to disseminate an off-label message about Treanda to prescribers.
News on Pfizer, Novartis, Teva, SternScientific, Roche and the PharmedOut Conference
ProPublica's Dollars for Docs database shows many firms continue to utilize physician speakers for non-CME product-related talks and consulting.
Although a popular part of the mix for some brands, meetings drew fewer dollars from pharma's coffers last year, according to research.
A panel following up on an anonymous complaint to UK industry self-policing arm PCMPA ruled for Roche in a case alleging inappropriate behavior at an overseas medical conference.
News on Pri-Med, Exhibitor magazine, Boehringer Ingelheim, QPharma and Elsevier
The final ruling regarding collecting data on industry payments to physicians from HHS's Centers for Medicare & Medicaid Services has several elements that are significant for medical education.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.